MDNA - Medicenna Therapeutics prices $20M stock offering

• Medicenna Therapeutics ( NASDAQ: MDNA ) on Tuesday has priced its 13.33M units offering to $1.50 each, resulting in gross proceeds of ~$20M.
• Each unit will be comprised of 1 common share and 1 share purchase warrant exercisable to purchase additional share at a price of $1.85 per share.
• The clinical stage immunotherapy company said it plans to use the net proceeds primarily to fund the clinical development of MDNA11 , the pre-clinical development of a BiSKIT candidate, working capital and for general corporate purposes.
• Closing of the offering is expected on Au. 11, 2022.
• Earlier: Medicenna Therapeutics GAAP EPS of -C$0.42

For further details see: